Healthcare and Medical

Cancer Diagnostics Market Growth Accelerated By Rising Adoption Of Personalized Medicine

Leena Shedmake

Cancer Diagnostics Market Growth Accelerated By Rising Adoption Of Personalized Medicine

Cancer diagnostics products assist in early detection and diagnosis of cancer with the help of tools and tests. Some common cancer diagnostics tools include biopsy, imaging tests, tumor biomarker tests, and liquid biopsy. These diagnostic tools offer non-invasive procedures to detect cancer at an early stage, monitor cancer treatment response, and determine the appropriate course of treatment. The rising adoption of personalized medicine and increasing preference for non-invasive diagnostic procedures are fueling the demand for advanced cancer diagnostic tools.

The global Cancer Diagnostics Market is estimated to be valued at US$ 59.01 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The introduction of liquid biopsy has accelerated the growth of the cancer diagnostics market. Liquid biopsy is a non-invasive procedure used to detect cancer by analyzing blood or other body fluid samples. It offers real-time monitoring of cancer progression and response to treatment with minimal risk and cost compared to invasive procedures. Liquid biopsy looks for cancer DNA circulating in the blood and can detect very small fragments of genetic material released by tumors into the bloodstream. Therefore, liquid biopsy is gaining popularity as it provides a less invasive alternative for tumor screening and recurrence monitoring. The adoption of liquid biopsy is expected to grow significantly over the forecast period as it enables timely treatment decisions and monitoring of cancer.

Segment Analysis

The global cancer diagnostics market is dominated by the imaging segment. Imaging technologies help detect cancer and examine its spread in the body and include modalities like MRI, CT scan, X-ray, ultrasound and others. Among these, CT scans and MRI imaging hold the largest share as they provide detailed pictures of soft tissues and internal organs. MRI is being widely used for screening, diagnosing, staging and restaging of cancers like prostate, breast, colon and lung.

Key Takeaways

The Global Cancer Diagnostics Market Demand is expected to witness high growth during the forecast period 2023 to 2030.

Regional Analysis: The North America region currently dominates the market and is expected to maintain its leading position throughout the forecast period. Growing prevalence of cancer, increasing awareness about early detection and presence of advanced healthcare infrastructure are driving the growth of cancer diagnostics market in North America.

Key players operating in the cancer diagnostics market are Borg Automotive A/S, Budweg Caliper A/S, Caterpillar Inc., LuK Unna GmbH & Co. KG, Valeo SA, Schouw & Co., ZF Friedrichshafen AG, Monark Automotive GmbH, Carwood Group, Robert Bosch GmbH, and Meritor, Inc. Borg Automotive A/S and Budweg Caliper A/S hold a major share of the brakes segment for commercial vehicles.Caterpillar Inc. and LuK Unna GmbH & Co. KG are leaders in the engine and parts segment respectively

Explore more information on this topic, Please visit-

https://www.marketwebjournal.com/cancer-diagnostics-market-growth-and-trnds-analysis-share-size-demand-forecast/

Explore more trending article related this topic-

https://www.shayaricenter.com/understanding-cancer-biomarkers

Leena Shedmake

Precision Medicine in Cancer Diagnostics: Targeting Therapeutic Solutions

Larry Paige 2023-07-26

Unlike traditional one-size-fits-all approaches, precision medicine takes into account individual genetic, molecular, and clinical factors to guide treatment decisions. Immunotherapy: Precision medicine has also revolutionized the use of immunotherapy in cancer treatment. Biomarkers identified through precision medicine can predict the likelihood of response to immunotherapy, guiding patient selection for these treatments. Clinical Trial Enrollment: Precision medicine facilitates patient enrollment in clinical trials that match their tumor's specific molecular profile. In conclusion, precision medicine in cancer diagnostics has transformed the landscape of cancer care by individualizing treatment strategies based on the molecular and genetic makeup of each patient's tumor.

Global Cancer Diagnostics Market Is Estimated To Witness High Growth Owing To Increasing Demand for Early Cancer Detection

Pooja salve 2023-08-21

The global Cancer Diagnostics market is estimated to be valued at US$ 59. A) Market Overview: The Cancer Diagnostics market includes various diagnostic tools and techniques used for the early detection, diagnosis, and management of cancer. The increasing prevalence of cancer and the need for early detection are driving the demand for cancer diagnostics. B) Market key trends: One key trend shaping the Cancer Diagnostics market is the growing emphasis on liquid biopsies. In conclusion, the global Cancer Diagnostics market is expected to witness significant growth due to increasing demand for early cancer detection.

Cancer Diagnostics Market Registered at CAGR 6.79% New Business Opportunities, Growth Rate, Development Trend and Feasibility Studies by 2028 | Data Bridge Market Research

Bishal Gupta 2022-06-27

Rising prevalence of cancer drives the cancer diagnostics market. The Global Cancer Diagnostics Market report also analyses the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. What are the top companies in the global Cancer Diagnostics Market? com/reports/global-cancer-diagnostics-marketSome of the Major Highlights of Toc Covered: –IntroductionAssumptions and Research MethodologyExecutive SummaryMarket OverviewKey InsightsGlobal Cancer Diagnostics Market Analysis and Forecast, By ProductEurope Cancer Diagnostics Market Analysis and ForecastAsia Pacific Cancer Diagnostics Market Analysis and ForecastLatin America Cancer Diagnostics Market Analysis and ForecastMiddle East & Africa Cancer Diagnostics Market Analysis and ForecastCompetitive Landscape Get TOC Details:https://www. dbmr=global-cancer-diagnostics-marketKey Players Cancer Diagnostics MarketThe major players covered in the Cancer Diagnostics Market report areAbbott,Agilent Technologies, Inc.

The Global Cancer Diagnostics Market Is Growing At An Accelerated Pace

kiran gire 2023-12-27

The global Cancer Diagnostics Market is estimated to be valued at US$ 59. It works by detecting proteins or markers on the surface of cancer cells that can help identify whether the cells came from a certain type of cancer like breast, lung or blood cancer. With the rising application of immunohistochemistry for diagnosing different cancer types, it is driving significant growth of the overall cancer diagnostics market during the forecast period. Segment Analysis The global cancer diagnostics market is dominated by imaging and molecular diagnostics segments. Factors such as increasing incidence of cancer, rising adoption of advanced imaging technologies and growing importance of early cancer diagnosis drive the regional market growth.

Antibodies Inc. Is Fastest Growing Segment Fueling The Growth Of Cancer Diagnostics Market

Ashish Thapa 2023-12-19

The global Cancer Diagnostics Market is estimated to be valued at US$ 59. Monoclonal antibodies bind to specific epitopes on cancer cells and help in early detection of various cancers including breast cancer, lung cancer and colorectal cancer. Segment AnalysisContent: The cancer diagnostics market is segmented into tumor type, technology, application, and end user. The tumor type segment is further divided into breast cancer, lung cancer, colorectal cancer, melanoma, and others. The breast cancer segment currently dominates the market due to the rising prevalence of breast cancer globally.

Cancer Diagnostics Market Competitive Landscape, Growth Factors, Revenue Analysis Till 2032

David 2023-09-21

com/request-sample/detail/2406Overall, the cancer diagnostics industry is segmented in terms of application, cancer, end-use, and region. Regionally, the Asia Pacific cancer diagnostics market is expected to grow significantly from 2023 to 2032. Request for customization @ https://www. , is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Toll Free: 1-888-689-0688USA: +1-302-846-7766Europe: +44-742-759-8484APAC: +65-3129-7718Email:sales@gminsights.

WHO TO FOLLOW